 Nitroimidazoles
"Nitroimidazoles" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D009593
|
| MeSH Number(s) |
D02.640.672 D03.383.129.308.658
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nitroimidazoles".
Below are MeSH descriptors whose meaning is more specific than "Nitroimidazoles".
This graph shows the total number of publications written about "Nitroimidazoles" by people in UAMS Profiles by year, and whether "Nitroimidazoles" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 1 | 0 | 1 | | 2018 | 0 | 1 | 1 | | 2015 | 1 | 1 | 2 | | 2013 | 0 | 1 | 1 | | 2012 | 0 | 1 | 1 | | 2011 | 0 | 1 | 1 | | 2006 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Nitroimidazoles" by people in Profiles over the past ten years.
-
Piccolo BD, Graham JL, Tabor-Simecka L, Randolph CE, Moody B, Robeson MS, Kang P, Fox R, Lan R, Pack L, Woford N, Yeruva L, LeRoith T, Stanhope KL, Havel PJ. Colonic epithelial hypoxia remains constant during the progression of diabetes in male UC Davis type 2 diabetes mellitus rats. BMJ Open Diabetes Res Care. 2024 Mar 07; 12(2).
-
Dadgar S, Troncoso JR, Rajaram N. Optical spectroscopic sensing of tumor hypoxia. J Biomed Opt. 2018 06; 23(6):1-6.
-
Koonce NA, Levy J, Hardee ME, Jamshidi-Parsian A, Vang KB, Sharma S, Raleigh JA, Dings RP, Griffin RJ. Targeting Artificial Tumor Stromal Targets for Molecular Imaging of Tumor Vascular Hypoxia. PLoS One. 2015; 10(8):e0135607.
-
Dawson R, Diacon AH, Everitt D, van Niekerk C, Donald PR, Burger DA, Schall R, Spigelman M, Conradie A, Eisenach K, Venter A, Ive P, Page-Shipp L, Variava E, Reither K, Ntinginya NE, Pym A, von Groote-Bidlingmaier F, Mendel CM. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis. Lancet. 2015 May 02; 385(9979):1738-1747.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|